Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1511-1520 of 3399 for cancer

Edit search filters
  1. A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

    Scottsdale/Phoenix, AZ

  2. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects

    Scottsdale/Phoenix, AZ

  3. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

    Rochester, MN, Jacksonville, FL, Scottsdale/Phoenix, AZ

  4. Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

    Rochester, MN

  5. Risk-Adapted Chemotherapy in Younger Patients with Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia

    Rochester, MN

  6. Embolization Before Ablation Of Renal Cell Carcinoma (EMBARC)"

    Rochester, MN

  7. Study of LY2784544 Testing Alternative Dosing in Participants with Myeloproliferative Neoplasms

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  8. A Study to Evaluate Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC

    Scottsdale/Phoenix, AZ

  9. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)

    Rochester, MN

  10. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer